Similar, clodronate encapsulated in liposomes administered into a mouse model of melanoma depleted TAMs and inhibited the monocyte chemoattractant protein 1 (MCP-1) pharmacologically, thereby reducing macrophage recruitment [213]. The gene discussed is CCL2; the disease is melanoma.